Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Gastrointestinal Neoplasms × Gefitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 33 Adenocarcinoma of Lung 9 Lung Neoplasms 8 NSCLC 5 Brain Neoplasms 5 Adenocarcinoma, Bronchiolo-Alveolar 3 Neoplasms 2 Adenocarcinoma 2 Triple Negative Breast Neoplasms 1 Skin Neoplasms 1 Non-squamous Non-small Cell Lung Cancer 1 Non-Small-Cell Lung 1 Liver Neoplasms 1 Gastrointestinal Neoplasms 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 EGFR Tyrosine Kinase Inhibitors Plus VEGFR Inhibitors 1 EGFR Mutation Positive Non-small Cell Lung Cancer 1 Drug-Related Side Effects and Adverse Reactions 1 Breast Neoplasms 1 Advanced Stage Non Small Cell Lung Cancer 1 Advanced Non-small Cell Lung Cancer 1 Advanced NSCLC With EGFR Mutation 1

Interventions

Drug Therapy 4 apatinib 3 Oxaliplatin 3 Irinotecan 3 pemigatinib 2 pembrolizumab 2 cemiplimab 2 avelumab 2 atezolizumab 2 S 1 (combination) 2 Nivolumab 2 Leucovorin 2 Folfox protocol 2 Fluorouracil 2 Everolimus 2 Erlotinib Hydrochloride 2 Endoscopic Mucosal Resection 2 Capecitabine 2 CGX1321 2 Bevacizumab 2 vandetanib 1 titanium silicide 1 tepotinib 1 tegafur-gimeracil-oteracil 1 talazoparib 1 sodium thiosulfate 1 selpercatinib 1 pralsetinib 1 ponatinib 1 phosphatidyltransferase, Clostridium butyricum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02013089 2016-08-30

GITIC

Sun Yat-sen University

Phase NA Unknown

Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡